Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway

Purpose: Functional impairment of endothelial progenitor cells (EPCs) is frequently observed in patients with diabetic vascular complications. Astragaloside IV (ASV) has a significant protective effect against vascular endothelial dysfunction. Thus, this study aimed to investigate the role of ASV on...

Full description

Saved in:
Bibliographic Details
Published in:Drug Des Devel Ther
Main Authors: Qian, Weibin, Cai, Xinrui, Qian, Qiuhai, Zhuang, Qianzhu, Yang, Wenjun, Zhang, Xinying, Zhao, Lijie
Format: Artigo
Language:Inglês
Published: Dove 2019
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6677131/
https://ncbi.nlm.nih.gov/pubmed/31440038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S207774
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items